Journal
ATHEROSCLEROSIS
Volume 281, Issue -, Pages 62-70Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2018.12.023
Keywords
Platelets; Obesity; Proteomics; GPVI signalling; SFK-Mediated signalling pathways; Drug targets
Funding
- Spanish Ministry of Economy and Competitiveness (MINECO) [SAF2016-79662-R]
- European Regional Development Fund (ERDF)
- Conselleria de Cultura, Educacion e Ordenacion Universitaria, Xunta de Galicia (Centro Singular de investigacion de Galicia accreditation 2016-2019) [ED431G/05]
- British Heart Foundation [SP/10/011/28199, RG/15/4/31268]
Ask authors/readers for more resources
Background and aims: Platelets play a fundamental role in the increased atherothrombotic risk related to central obesity since they show hyperactivation and lower sensitivity to antiplatelet therapy in obese patients. The main goal of this study was to identify platelet biomarkers related to the risk of atherothrombosis in obese patients, confirm platelet activation levels in these patients, and identify altered activation pathways. Methods: Platelets were obtained from cohorts of obese patients and age-and sex-matched lean controls. Biochemical and proteome analyses were done by two-dimensional differential in-gel electrophoresis (2D-DIGE), mass spectrometry, and immunoblotting. Functional and mechanistic studies were conducted with aggregation assays and flow cytometry. Results: We confirmed an up-regulation of alpha IIb and fibrinogen isoforms in platelets from obese patients. A complementary platelet aggregation approach showed platelets from obese patients are hyper-reactive in response to collagen and collagen-related peptide (CRP), revealing the collagen receptor Glycoprotein VI (GPVI) signalling as one of the altered pathways. We also found the active form of Src (pTyr418) is up-regulated in platelets from obese individuals, which links proteomics to aggregation data. Moreover, we showed that CRP-activated platelets present higher levels of tyrosine phosphorylated PLC gamma 2 in obese patients, confirming alterations in GPVI signalling. In line with the above, flow cytometry studies show higher surface expression levels of total GPVI and GPVI-dimer in obese platelets, both correlating with BMI. Conclusions: Our results suggest a higher activation state of SFKs-mediated signalling pathways in platelets from obese patients, with a primary involvement of GPVI signalling.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available